Endocrinology, Vol 137, 5250-5254, Copyright © 1996 by Endocrine Society

ARTICLES

Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3'-triiodothyronine syndrome

A Boelen, MA Maas, CW Lowik, MC Platvoet and WM Wiersinga
Department of Endocrinology, Academic Medical Center, University of Amsterdam, The Netherlands.

Interleukin-6 (IL-6) administration to human subjects or experimental animals induces changes in thyroid hormone metabolism resembling those in the sick euthyroid syndrome. Furthermore, the decrease in serum T3 during illness is significantly related to serum IL-6 concentrations. These findings suggest, but do not prove, a causal role for IL-6 in the development of the low T3 syndrome. The aim of the present study was to evaluate the role of IL-6 in the development of the sick euthyroid syndrome in IL-6 knock-out (IL-6(-/-)) mice compared to that in wild- type mice (IL-6(+/+)). Illness was induced in IL-6(-/-) and IL-6(+/+) mice by 1) administration of bacterial endotoxin (LPS), 2) infection with Listeria monocytogenes, and 3) turpentine injection in both hind limbs. Food intake was kept similar in both groups in all three experiments. Serial measurements were made of serum IL-6, tumor necrosis factor-alpha, T3, T4, corticosterone, and liver 5'-deiodinase (5'-DI) messenger RNA (mRNA) for 24 h (LPS), 96 h (L. monocytogenes), and 48 h (turpentine). Serum IL-6 increased in response to all stimuli in IL-6(+/+) mice, but not in IL-6(-/-) mice. Serum tumor necrosis factor-alpha was induced by LPS in both groups to a similar extent, but did not rise after L. monocytogenes or turpentine administration. Serum T3 and T4 decreased after all three stimuli. The decrease in serum T4 in IL-6(-/-) was similar to that in IL-6(+/+) mice. The decrease in serum T3, however, was smaller in the IL-6(-/-) mice than in the IL- 6(+/+) mice; T3 levels were 1.56 +/- 0.29 and 0.99 +/- 0.15 nmol/liter, respectively, 24 h after LPS treatment (P < 0.01), 2.39 +/- 0.17 and 1.75 +/- 0.24 nmol/liter 96 h after L. monocytogenes treatment (P < 0.01), and 1.46 +/- 0.18 and 1.10 +/- 0.25 nmol/liter 48 h after turpentine treatment (P < 0.05). The smaller fall in serum T3 in IL-6(- /-) mice could not be attributed to differences in the severity of the induced illness, food intake, or corticosterone response, which were all similar in IL-6(-/-) mice and IL-6(+/+) mice. Liver 5'-deiodinase mRNA decreased after all three stimuli; the decrease after LPS and L. monocytogenes infection was smaller in the IL-6(-/-) mice, but the difference in IL-6(+/+) mice just failed to reached statistical significance. Liver 5'-deiodinase activity after turpentine injection administration decreased in the wild-type animals by 36%, but did not change in the knock-out mice. In conclusion, acutely induced illness generates the low T3 syndrome, which is less marked in IL-6 knock-out mice than in wild-type mice. The data suggest a causal role of IL-6 in the development of the low T3 syndrome.

This article has been cited by other articles:

				I. Klein and S. Danzi Thyroid Hormone Treatment to Mend a Broken Heart J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1172 - 1174. [Full Text] [PDF]

				R. Rocchi, H. Kimura, S.-C. Tzou, K. Suzuki, N. R. Rose, A. Pinchera, P. W. Ladenson, and P. Caturegli Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness PNAS, April 3, 2007; 104(14): 6019 - 6024. [Abstract] [Full Text] [PDF]

				G. Enia, V. Panuccio, S. Cutrupi, P. Pizzini, G. Tripepi, F. Mallamaci, and C. Zoccali Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis Nephrol. Dial. Transplant., February 1, 2007; 22(2): 538 - 544. [Abstract] [Full Text] [PDF]

				L. Fontana, S. Klein, J. O. Holloszy, and B. N. Premachandra Effect of Long-Term Calorie Restriction with Adequate Protein and Micronutrients on Thyroid Hormones J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3232 - 3235. [Abstract] [Full Text] [PDF]

				J. Yu and R. J. Koenig Induction of Type 1 Iodothyronine Deiodinase to Prevent the Nonthyroidal Illness Syndrome in Mice Endocrinology, July 1, 2006; 147(7): 3580 - 3585. [Abstract] [Full Text] [PDF]

				J Kwakkel, W M Wiersinga, and A Boelen Differential involvement of nuclear factor-{kappa}B and activator protein-1 pathways in the interleukin-1{beta}-mediated decrease of deiodinase type 1 and thyroid hormone receptor {beta}1 mRNA. J. Endocrinol., April 1, 2006; 189(1): 37 - 44. [Abstract] [Full Text] [PDF]

				A. Boelen, J. Kwakkel, A. Alkemade, R. Renckens, E. Kaptein, G. Kuiper, W. M. Wiersinga, and T. J. Visser Induction of Type 3 Deiodinase Activity in Inflammatory Cells of Mice with Chronic Local Inflammation Endocrinology, December 1, 2005; 146(12): 5128 - 5134. [Abstract] [Full Text] [PDF]

				C. Zoccali, G. Tripepi, S. Cutrupi, P. Pizzini, and F. Mallamaci Low Triiodothyronine: A New Facet of Inflammation in End-Stage Renal Disease J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2789 - 2795. [Abstract] [Full Text] [PDF]

				N. Caraccio, F. Monzani, E. Santini, S. Cuccato, D. Ferrari, M. G. Callegari, S. Gulinelli, C. Pizzirani, F. Di Virgilio, E. Ferrannini, et al. Extracellular Adenosine 5'-Triphosphate Modulates Interleukin-6 Production by Human Thyrocytes through Functional Purinergic P2 Receptors Endocrinology, July 1, 2005; 146(7): 3172 - 3178. [Abstract] [Full Text] [PDF]

				F. Weekers, M. Michalaki, W. Coopmans, E. Van Herck, J. D. Veldhuis, V. M. Darras, and G. Van den Berghe Endocrine and Metabolic Effects of Growth Hormone (GH) Compared with GH-Releasing Peptide, Thyrotropin-Releasing Hormone, and Insulin Infusion in a Rabbit Model of Prolonged Critical Illness Endocrinology, January 1, 2004; 145(1): 205 - 213. [Abstract] [Full Text] [PDF]

				S. Chandrasekharan, T. H. Qiu, N. Alkharouf, K. Brantley, J. B. Mitchell, and E. T. Liu Characterization of Mice Deficient in the Src Family Nonreceptor Tyrosine Kinase Frk/rak Mol. Cell. Biol., July 15, 2002; 22(14): 5235 - 5247. [Abstract] [Full Text] [PDF]

				C. Cebo, V. Durier, P. Lagant, E. Maes, D. Florea, T. Lefebvre, G. Strecker, G. Vergoten, and J.-P. Zanetta Function and Molecular Modeling of the Interaction between Human Interleukin 6 and Its HNK-1 Oligosaccharide Ligands J. Biol. Chem., March 29, 2002; 277(14): 12246 - 12252. [Abstract] [Full Text] [PDF]

				M. Michalaki, A. G. Vagenakis, M. Makri, F. Kalfarentzos, and V. Kyriazopoulou Dissociation of the Early Decline in Serum T3 Concentration and Serum IL-6 Rise and TNF{alpha} in Nonthyroidal Illness Syndrome Induced by Abdominal Surgery J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4198 - 4205. [Abstract] [Full Text] [PDF]

				D. A. Papanicolaou Interleukin-6: The Endocrine Cytokine J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1331 - 1333. [Full Text]

				T. van der Poll, E. Endert, S. M. Coyle, J. M. Agosti, and S. F. Lowry Neutralization of TNF does not influence endotoxininduced changes in thyroid hormone metabolism in humans Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R357 - R362. [Abstract] [Full Text] [PDF]

				J. Yu and R. J. Koenig Regulation of Hepatocyte Thyroxine 5'-Deiodinase by T3 and Nuclear Receptor Coactivators as a Model of the Sick Euthyroid Syndrome J. Biol. Chem., December 1, 2000; 275(49): 38296 - 38301. [Abstract] [Full Text] [PDF]